🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, alleging the firms hid potential risks that the pain reliever posed to pediatric neurological development.

The lawsuit arrives four weeks after President Donald Trump promoted an unverified association between consuming acetaminophen - alternatively called acetaminophen - while pregnant and autism in children.

The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a official comment, he said they "betrayed America by profiting off of discomfort and pushing pills regardless of the potential hazards."

The manufacturer says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking millions to line their pockets," the attorney general, a Republican, stated.

Kenvue commented that it was "seriously troubled by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its official site, the company also mentioned it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between taking paracetamol and autism."

Organizations acting on behalf of doctors and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in acetaminophen - is one of the few options for women during pregnancy to manage pain and elevated temperature, which can present significant medical dangers if ignored.

"In over twenty years of investigation on the consumption of paracetamol in gestation, no reliable research has definitively established that the use of paracetamol in any stage of pregnancy results in neurodevelopmental disorders in children," the association commented.

The court filing mentions recent announcements from the Trump administration in asserting the drug is reportedly hazardous.

Recently, Trump generated worry from public health officials when he advised pregnant women to "resist strongly" not to use acetaminophen when unwell.

The FDA then released a statement that physicians should think about restricting the consumption of Tylenol, while also stating that "a proven link" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Kennedy, who manages the FDA, had pledged in spring to undertake "extensive scientific investigation" that would determine the cause of autism in a limited time.

But specialists advised that identifying a sole reason of autism - considered by experts to be the outcome of a complex mix of inherited and external influences - would not be simple.

Autism is a category of lifelong neurodivergence and disability that impacts how individuals perceive and relate to the environment, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - aligned with the former president who is seeking federal office - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The case aims to force the corporations "eliminate any commercial messaging" that asserts Tylenol is secure for women during pregnancy.

The court case mirrors the grievances of a assembly of parents of minors with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in 2022.

Judicial authorities dismissed the legal action, declaring studies from the family's specialists was not conclusive.